KMIT-ACC
Financiado
Digital Variance Angiography a ground breaking X ray angiography innovation do...
Digital Variance Angiography a ground breaking X ray angiography innovation dose management and quality enhancement by Kinepict Medical Imaging Tool
Cardiovascular disorders are the number one health problem in the high-income societies. X-ray imaging of blood vessels is widely used in diagnosis and treatment of cardiovascular conditions, but it has several drawbacks: Image qu...
Cardiovascular disorders are the number one health problem in the high-income societies. X-ray imaging of blood vessels is widely used in diagnosis and treatment of cardiovascular conditions, but it has several drawbacks: Image quality is sometimes insufficient; Applied Iodinated Contrast Media (ICM) may induce kidney injuries; X-ray exposure of patient and staff may cause cancer. Image quality improvement and radical reduction of ICM/X-ray dose are an unmet need. Our team has developed Digital Variance Angiography imaging and implemented it in a software, the Kinepict Medical Imaging Tool (KMIT). This ground-breaking patented technology can change the currently used angiography methods, improving image quality (3-10 times higher signal-to-noise ratio) and providing a dose management solution to reduce X-ray and ICM dose at least by 75% and 50%, respectively. Using the KMIT offers several advantages: a)Risk of angiography procedures is reduced dramatically for both patient and staff. b)The society benefits from smaller morbidity and mortality of cancer and kidney injury c)Hospitals save 220,000 €/year on direct costs d)Health care system expenses are reduced by around 300,000 €/year/licencing hospital e)Total savings might reach the 300 M€/year in the EU (assuming a 10 % market penetration. Our customers are healthcare institutions doing vascular interventions; the users of our product are vascular surgeons and interventional radiologists. Our total addressable market size in Europe and USA is around €300 M. Our goal is to revolutionize X-ray angiography by introducing a dose management and image processing tool. The current proposal is organized around the following objectives: a) clinical validation of our technology for new indications, b) organization of a reference laboratory network, c) software and hardware optimization to reach TRL 9 level and d) baseline commercial activities.
ver más
Duración del proyecto: 29 meses
Fecha Inicio: 2021-03-17
Fecha Fin: 2023-08-31
Fecha Fin: 2023-08-31
Línea de financiación: concedida
El organismo H2020 notifico la concesión del proyecto el día 2023-08-31
Línea de financiación objetivo
El proyecto se financió a través de la siguiente ayuda:
EIC-SMEInst-2018-2020:
SME instrument
Cerrada
hace 6 años
Presupuesto
El presupuesto total del proyecto asciende a
2M€
Líder del proyecto
KINEPICT HEALTH KORLATOLT FELELOSSEGU TARSASA...
No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico
TRL
4-5
Perfil tecnológico
TRL
4-5
600.00K€ |
Participante